Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chaffanet, M"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1421
Tytuł:
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
Autorzy:
Collignon, A.
Hospital, M. A.
Montersino, C.
Courtier, F.
Charbonnier, A.
Saillard, C.
D’Incan, E.
Mohty, B.
Guille, A.
Adelaïde, J.
Carbuccia, N.
Garnier, S.
Mozziconacci, M. J.
Zemmour, C.
Pakradouni, J.
Restouin, A.
Castellano, R.
Chaffanet, M.
Birnbaum, D.
Collette, Y.
Vey, N.
Pokaż więcej
Źródło:
Blood Cancer Journal. 10(6)
Czasopismo naukowe
Szczegóły
Tytuł:
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.
Autorzy:
Udu-Ituma S; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; Department of Biology, Alex Ekwueme Federal University Ndufu-Alike Ikwo, Abakaliki P.M.B. 1010, Ebonyi State, Nigeria.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Adélaïde J; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Le TK; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Omabe K; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Finetti P; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Paris C; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Guille A; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Bertucci F; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Birnbaum D; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Rocchi P; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Chaffanet M; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2023 Jul 11; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth
Autorzy:
Fournier, GAff1, Aff4, Aff5
Cabaud, OAff1, Aff4, Aff5
Josselin, EAff1, Aff4, Aff5
Chaix, AAff2, Aff4, Aff5
Adélaïde, JAff4, Aff5
Isnardon, DAff4, Aff5
Restouin, AAff3, Aff4, Aff5
Castellano, RAff3, Aff4, Aff5
Dubreuil, PAff2, Aff4, Aff5
Chaffanet, MAff1, Aff4, Aff5
Birnbaum, D
Lopez, MAff1, Aff4, Aff5, IDonc2011106_cor12
Pokaż więcej
Źródło:
Oncogene. 30(36):3862-3874
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Autorzy:
Billon E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Guille A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Carbuccia N; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Adelaide J; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Garnier S; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Finetti P; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Denicolaï E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, 13009 Marseille, France.
Brunelle S; Department of Imaging, Institut Paoli-Calmettes, 13009 Marseille, France.
Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pignot G; Department of Urology, Institut Paoli-Calmettes, 13009 Marseille, France.
Walz J; Department of Urology, Institut Paoli-Calmettes, 13009 Marseille, France.
Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, 13009 Marseille, France.
Sabatier R; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Vicier C; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, 13009 Marseille, France.
Mamessier E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Gonçalves A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Birnbaum D; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Chaffanet M; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Bertucci F; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 May 03; Vol. 14 (9). Date of Electronic Publication: 2022 May 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes
Autorzy:
Gelsi-Boyer, VAff1, Aff7, Aff5, Aff2, Aff3
Cervera, NAff1, Aff7, Aff5
Bertucci, FAff1, Aff7, Aff5, Aff3
Trouplin, VAff1, Aff7, Aff5, Aff2
Remy, VAff1, Aff7, Aff5
Olschwang, SAff1, Aff7, Aff5
Chaffanet, MAff1, Aff7, Aff5
Vey, N
Mozziconacci, M-JAff1, Aff7, Aff5, Aff2
Birnbaum, DAff1, Aff7, Aff5, ID2404805_cor10
Pokaż więcej
Źródło:
Leukemia. 21(11):2359-2362
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
Autorzy:
Letessier, A
Garrido-Urbani, S
Ginestier, C
Fournier, G
Esterni, BAff3, Aff4
Monville, F
Adélaïde, J
Geneix, J
Xerri, LAff5, Aff6
Dubreuil, P
Viens, PAff4, Aff6
Charafe-Jauffret, EAff1, Aff5, Aff6
Jacquemier, JAff1, Aff5
Birnbaum, DAff1, ID1209772_cor14
Lopez, M
Chaffanet, M
Pokaż więcej
Źródło:
Oncogene. 26(2):298-307
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
Autorzy:
Murati, AAff1, Aff2
Gelsi-Boyer, VAff1, Aff2, Aff3
Adélaïde, J
Perot, C
Talmant, P
Giraudier, S
Lodé, L
Letessier, A
Delaval, B
Brunel, V
Imbert, M
Garand, R
Xerri, LAff2, Aff3
Birnbaum, D
Mozziconacci, M JAff1, Aff2, ID2403879_cor15
Chaffanet, M
Pokaż więcej
Źródło:
Leukemia. 19(9):1692-1696
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Autorzy:
Bertucci F; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France. .; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. .
Gonçalves A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Guille A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Adelaïde J; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Garnier S; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Carbuccia N; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Billon E; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Finetti P; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France.
Monneur A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Pécheux C; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.
Khran M; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.; Aix-Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France.
Brunelle S; Department of Imaging, Institut Paoli-Calmettes, Marseille, France.
Mescam L; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Poizat F; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Charafe-Jauffret E; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Lambaudie E; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Extra JM; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Mamessier E; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, UMR981 Inserm, Villejuif, France.; Paris Sud University, Orsay, France.
Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France.
Birnbaum D; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chaffanet M; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2021 May 18; Vol. 13 (1), pp. 87. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Genomics*/methods
High-Throughput Nucleotide Sequencing*
Neoplasms/*diagnosis
Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Combined Modality Therapy ; Comparative Genomic Hybridization ; Disease Management ; Disease Susceptibility ; Female ; Genetic Variation ; Humans ; Male ; Middle Aged ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms/mortality ; Neoplasms/therapy ; Precision Medicine/methods ; Prognosis ; Prospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mutations and deletions of ARID1A in breast tumors
Autorzy:
Cornen, SAff1, Aff4, Aff5, Aff6
Adelaide, JAff1, Aff4, Aff5, Aff6
Bertucci, FAff1, Aff4, Aff5, Aff6, Aff2, Aff3
Finetti, PAff1, Aff4, Aff5, Aff6
Guille, AAff1, Aff4, Aff5, Aff6
Birnbaum, D JAff1, Aff4, Aff5, Aff6
Birnbaum, DAff1, Aff4, Aff5, Aff6
Chaffanet, MAff1, Aff4, Aff5, Aff6, IDonc2011598_cor8
Pokaż więcej
Źródło:
Oncogene. 31(38):4255-4256
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 1421

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies